Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Spengler

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Analyst|July 22, 2015
Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniquesMark Spengler, Michael Adler, Christof M Niemeyer
Biochemical and Biophysical Research Communications|July 7, 2009
Immuno-PCR assays for immunogenicity testingMark Spengler, Michael Adler, Andreas Jonas, et al.
Molecular Biosystems|August 2, 2006
Synthesis of covalent DNA-protein conjugates by expressed protein ligationMarina Lovrinovic, Mark Spengler, Carl Deutsch, et al.
Chembiochem : a European Journal of Chemical Biology|November 8, 2007
Light-induced triggering of peroxidase activity using quantum dotsLjiljana Fruk, Vidyalakshmi Rajendran, Mark Spengler, et al.
Biochemical and Biophysical Research Communications|May 10, 2017
Immuno-PCR with digital readoutHendrik Schröder, Maximilian Grösche, Michael Adler, et al.
Analytical and Bioanalytical Chemistry|July 16, 2008
Engineering and assaying of cytochrome P450 biocatalystsKersten S Rabe, Valérie J Gandubert, Mark Spengler, et al.
Chembiochem : a European Journal of Chemical Biology|February 26, 2009
Screening for cytochrome p450 reactivity by harnessing catalase as reporter enzymeKersten S Rabe, Mark Spengler, Michael Erkelenz, et al.
The AAPS Journal|October 22, 2014
Emerging technologies to increase ligand binding assay sensitivitySaloumeh K Fischer, Alison Joyce, Mark Spengler, et al.
NPJ Vaccines|May 22, 2020
New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routesMario Amacker, Charli Smardon, Laura Mason, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Analyst|July 22, 2015
Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniquesMark Spengler, Michael Adler, Christof M Niemeyer
Biochemical and Biophysical Research Communications|July 7, 2009
Immuno-PCR assays for immunogenicity testingMark Spengler, Michael Adler, Andreas Jonas, et al.
Molecular Biosystems|August 2, 2006
Synthesis of covalent DNA-protein conjugates by expressed protein ligationMarina Lovrinovic, Mark Spengler, Carl Deutsch, et al.
Chembiochem : a European Journal of Chemical Biology|November 8, 2007
Light-induced triggering of peroxidase activity using quantum dotsLjiljana Fruk, Vidyalakshmi Rajendran, Mark Spengler, et al.
Biochemical and Biophysical Research Communications|May 10, 2017
Immuno-PCR with digital readoutHendrik Schröder, Maximilian Grösche, Michael Adler, et al.
Analytical and Bioanalytical Chemistry|July 16, 2008
Engineering and assaying of cytochrome P450 biocatalystsKersten S Rabe, Valérie J Gandubert, Mark Spengler, et al.
Chembiochem : a European Journal of Chemical Biology|February 26, 2009
Screening for cytochrome p450 reactivity by harnessing catalase as reporter enzymeKersten S Rabe, Mark Spengler, Michael Erkelenz, et al.
The AAPS Journal|October 22, 2014
Emerging technologies to increase ligand binding assay sensitivitySaloumeh K Fischer, Alison Joyce, Mark Spengler, et al.
NPJ Vaccines|May 22, 2020
New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routesMario Amacker, Charli Smardon, Laura Mason, et al.
Pageof 1